Diabetic Nephropathy News and Research

RSS
Diabetic nephropathy is kidney disease or damage that results as a complication of diabetes.
Concert to initiate CTP-499 Phase 2 diabetic nephropathy clinical trial in 2012

Concert to initiate CTP-499 Phase 2 diabetic nephropathy clinical trial in 2012

Positive results from ChemoCentryx CCX354 Phase II study on RA

Positive results from ChemoCentryx CCX354 Phase II study on RA

Arginase-2 enzyme plays a major role in diabetic nephropathy

Arginase-2 enzyme plays a major role in diabetic nephropathy

JDC receives NIDDK grant for research into diabetic retinopathy, kidney disease

JDC receives NIDDK grant for research into diabetic retinopathy, kidney disease

Sulodexide drug fails to benefit diabetes patients with kidney disease

Sulodexide drug fails to benefit diabetes patients with kidney disease

Data from Concert Pharmaceuticals' CTP-499 study to be presented at ASN Kidney Week 2011

Data from Concert Pharmaceuticals' CTP-499 study to be presented at ASN Kidney Week 2011

ChemoCentryx commences CCX168 Phase II trial in ANCA-associated vasculitis

ChemoCentryx commences CCX168 Phase II trial in ANCA-associated vasculitis

UC San Diego professor receives NIDDK grant to study kidney complications related to diabetes

UC San Diego professor receives NIDDK grant to study kidney complications related to diabetes

Lack of kidney dopamine leads to high blood pressure and shorter life span

Lack of kidney dopamine leads to high blood pressure and shorter life span

ASN President discusses latest information about diabetic nephropathy at ADA

ASN President discusses latest information about diabetic nephropathy at ADA

Relypsa initiates dosing in RLY5016 Phase 2b trial for hyperkalemia in diabetic nephropathy and CKD patients

Relypsa initiates dosing in RLY5016 Phase 2b trial for hyperkalemia in diabetic nephropathy and CKD patients

ChemoCentryx CCX140 Phase II study on type 2 diabetes meets primary endpoint

ChemoCentryx CCX140 Phase II study on type 2 diabetes meets primary endpoint

Boehringer Ingelheim, Lilly announce new data from linagliptin Phase III study on type 2 diabetes

Boehringer Ingelheim, Lilly announce new data from linagliptin Phase III study on type 2 diabetes

Concert to advance CTP-499, C-21191 into Phase 2 trials for diabetic nephropathy and spasticity

Concert to advance CTP-499, C-21191 into Phase 2 trials for diabetic nephropathy and spasticity

Researchers replicate progression of inflammatory gene changes of kidney from mild to severe diabetic nephropathy

Researchers replicate progression of inflammatory gene changes of kidney from mild to severe diabetic nephropathy

PVT1 gene may help reduce diabetic nephropathy

PVT1 gene may help reduce diabetic nephropathy

JASN publishes positive results from pirfenidone study in diabetic nephropathy

JASN publishes positive results from pirfenidone study in diabetic nephropathy

Ketogenic diet may reverse impaired kidney function in diabetics

Ketogenic diet may reverse impaired kidney function in diabetics

New study: Periodontal therapy can help reduce medical costs for patients with diabetes

New study: Periodontal therapy can help reduce medical costs for patients with diabetes

Concert initiates CTP-499 Phase 1 study in patients with diabetic nephropathy

Concert initiates CTP-499 Phase 1 study in patients with diabetic nephropathy